Biotech

iQ3Corp Ltd (ASX:IQ3) Appointment as Corporate Advisor for the Acquisition of Emedia Creative

🕔11/17/2015 10:58:52 AM

iQ3Corp Ltd (ASX:iQ3) is pleased to announce that it has today been appointed to act as corporate advisor to the parties to the in Principal Agreement by iQnovate Limited (IQN) to acquire a 50% equity stake in Emedia Creative Pty Ltd (Emedia) and the proposed listing of Emedia on the ASX.

Read Full Article

iQ3Corp Ltd (ASX:IQ3) Chairman's Address to Shareholders - 2015 AGM

🕔11/16/2015 7:34:42 PM

iQ3Corp Ltd (ASX:IQ3) are pleased to provide the Chairman's Address to Shareholders at the 2015 Annual General Meeting (AGM).

Read Full Article

Regeneus Ltd (ASX:RGS) Patent Granted for Allogeneic Stem Cell Technology Platform

🕔11/11/2015 9:39:27 AM

Regeneus (ASX:RGS), a clinical-stage regenerative medicine company, today announced that the Australian Patent Office has granted a key patent covering the use of the company's allogeneic "off-the-shelf" stem cell technology for the treatment of osteoarthritis and other inflammatory conditions for human and animal applications.

Read Full Article

Regeneus Ltd (ASX:RGS) Chairman's Address and CEO Presentation To Shareholders

🕔11/9/2015 3:10:52 PM

We are pleased to report that FY15 has been a productive and positive year for Regeneus Ltd (ASX:RGS). We have achieved a number of significant research and development, clinical and business milestones that have put the company in a good position to unlock value in our regenerative medicine technology and clinical assets in FY16 and beyond.

Read Full Article

Regeneus Ltd (ASX:RGS) Positive Clinical Results for CryoShot Equine

🕔11/5/2015 9:26:32 AM

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, announced today interim trial results showing that its allogeneic "off-the-shelf" stem cell therapy, CryoShot, has positive results on early orthopaedic developmental disease in Yearling Thoroughbreds and compares favourably against the use of conventional therapies like corticosteroids.

Read Full Article

Regeneus Ltd (ASX:RGS) Partners with a Leading Animal Health Company

🕔11/2/2015 9:10:05 AM

Regeneus (ASX:RGS), a clinical-stage regenerative medicine company, announced today that it had entered into an agreement with one of the world's top 5 animal health companies to partner the development and commercialisation of CryoShot Canine.

Read Full Article

Rhinomed Ltd (ASX:RNO) Quarterly Report

🕔10/30/2015 12:35:52 PM

Rhinomed (ASX:RNO) has had a strong first quarter of the financial year with positive traction across its consumer health and clinical businesses.

Read Full Article